Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of EARNS-Q Preference Module in Seasonal Allergic Rhinitis
NCT00346775Phase 3Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in seasonal allergic rhinitis (SAR), sponsored by GSK. Started May 2006; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00346775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346775.